Combined method for simultaneous morphology, immunophenotype and karyotype (MAC) in leukemias by Chauffaille, Maria de Lourdes Lopes Ferrari et al.
Maria de Lourdes Lopes Ferrari Chauffaille, Vicente Coutinho,
Mihoko Yamamoto, José Kerbauy
Combined method for simultaneous morphology,
immunophenotype and karyotype (MAC) in leukemias
Discipline of Hematology and Hemotherapy, Escola Paulista de Medicina-UNIFESP- São Paulo, Brazil
In the present study, a combined method (CM) for attaining simultaneous identification of leukemic cell morphology, karyotype and
immunophenotype has been evaluated in 21 patients with acute leukemia and 1with CML in blast crisis were studied for morphology,
citochemistry, immunophenotype and karyotype. Karyotype was performed in abone marrow sample by using conventional tech-
niques. In each case, direct method (DM) and/or three cultures were tried. The CM consisted in separating a small part of the material
resulting from any of the cultures or DM, preparing slides through cytospin and immunophenotyping through APAAP method using the
same monoclonal antibodies (MoAb) as for diagnosis. In 14 cases, the metaphases proved positive to the MoAb: in 4, the cells with
abnormality had their origin defined; in other 4 the karyotype was normal preventing any identification; 6 cases had minimal abnor-
malities not visible through CM; and in two cases abnormal karyotypes were detected only in the cultures with GM-CSF: '
This study showed that CM is feasible in cases where evident numerical or structural chromosomal abnormalties are present.
UNITERMS: Leukemia, chromosomes, immunophenotype.
INTRODUCTION
Several of the cytogenetic abnormalities in acuteleukemias are of clinicaI importance, once they.associate with distinctive modes in which the disease
presents itself as well as to prognostic factors.1.2
The acquisition of immunophenotyping and
cytogenetic data has led to a morphologic,
immunophenotypic and chromosomal (MIC) classification
3.4.5 which relates morphological subgroups within FAB
subtypes with specific karyotype abnormalities.
Methods that allow the simultaneous analysis of
morphology, immunophenotype and karyotype (MAC)
have been described and deserve particular attention. 6.7.X.9.1O
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The idea of concomitantly studying such aspects is of
major interest especially in leukemias, as it could possibly
indicate the cell lineagers which present chrolnosolnal
abnormalities. It may as well indicate the involvelnent of
different celllineages thus corroborating the heterogeneity
of leukemias. lO And finally, the combined Inethod lnakes
the analysis of a particular cell possible.
The main differences of the cOlnbined lnethod when
compared to the conventional technique are: hypotonic
treatment (using distilleq water instead of KCl), which
leaves cytoplasln and cell membrane intact, through the
utilization of cytospin in the place' of air drying Slnears
and the abandon of acid fixatives. lO
Few studies on th~ application of this method to
leukemic samples have been published up to the present
moment, mostly analysing cases where nUlnerical
chromosomal abnormalities occurred with results of lnuch
consequence.9•IO By means of this technique the
involvement of multiple lineages (i.e. erythrocytic,
myelomonocytic ar megakaryocytic) has been
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elelTIOnstrateel in some cases of acute myeloiel Ieukemia
(AML) with lTIOnOsomy 7. However, not alI the cases of
AML with trisomy 8 elemonstrateel such involvement. 7
We believe that the regular application of this lTIethoel,
though tilTIe consuming, woulel proviele invaluable
information on leukelTIic cell origino Thus, we inteneleel to .
elevelop anel evaluate the feasibility ofthis CM as a regular
proceelure, using a alkaline phosphatase anti-alkaline
phosphatase (APAAP) kit.
MATERIAL AND METHODS
Twenty-one patients with acute leukemia (18 AML, 2
acute IYlTIphoielleukelTIia - ALL- anel 1 lTIixeelleukelTIia)
anel 1 with chronic myeloiel leukelTIia (CML) in blast crisis
who were aellTIitteel to Hospital S. Paulo have been
investigateel, or those whose samples (cases 16 anel 20) had
been sent to us for analysis, from June to December 1992.
The average age of these subjects was 32 years (ranging
frOlTI2 lTIonths to 65 years), being 9 male anel 13 felTIale.
The acute leukemia was diagnoseel in the presence
ofblast cells in the patients' peripheral blood or more than
30% of thelTI in bone marrow.11.12 Bone lTIarrOW and
peripheral blood Sl11earSwere stained for Leishman, SuelalTI
Black B (SBB), Peroxielase (POX), periodic aciel Schiff
(PAS), naftol-ASD esterase (ASD), alfa naftil acetate
esterase (aES), NaF anel acid phosphatase (Fác)13 for
lTIorphological and cytochemical diagnosis of the acute
leukemia and classified according to FAB. 11.I4.15.ló
Bone lnarrow were collected with heparin, separated
by Ficoll Hypaque (Phannacia AB/ Wintrobe) gradient,
and then divided for 3 different purposes: for
imlnunophenotyping, cytogenetic and CM.
Immunophenotyping was performed by indirect
ilnlnunofluorescence, using the following MoAb: CD
33(My 9), CD 13 (My 7), CD 14 (Leu 9), CD 19 (B4), CD
41 (plt I), CD 10 (calla), SIg (Coulter) and CD 7 (Dako,
Beckton&Dickson)(Table I). Positivity was considered
when more than 20% of cells were stained. Bone lnarrow
cells separated by Ficoll-Hypaque gradient were washed 3
tilnes in phosphate buffered solution (PBS), resuspended
in RPMI 1640 medium (final concentration= 2x 1Oócells/
lnl) and divided into different tubes with mouse antibody
and incubated for 30 lTIinutes at 4°C. Then fIuorescent anti-
1110useantibody was added for 30 min in a cold CalTIera.
The ceIls were washed in PBS for 2 tilTIeS,the slides prepared
and 100 ceIls were counted in fluorescent microscope. 17
For cytogenetic and CM studies, bone lnarrow cells
were cultivated in a 25 ClTI3tissue culture flask with Sml
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RPMI 1640 (Sigma) medium, pH 7.0,200/0 fetal calf serUln
(Cultilab), L-glutamine 2mM (Sigma) and penicillin-
streptomicin (1OOU; 1OOug/mI). Depeneling on the amount
of lTIaterial obtained (visual observation), 2 or 3 cultures
were set up: a short term culture (S), a synchronised culture
(MTX), a culture with GM-CSF (GM) and/or a elirect
methoel (DM). The cultures were prepareel as follows: S
culture: was cultivated for 24 hours at 37°C; MTX culture:
ametopterine (MethotrexateR-Leelerle) was aelded 5 hours
after set up (final concentration=10-7 M) for 17 hours at
37°C anel thymidine (Sigma) was added (final
concentration= 10-5 M) for the last 5 hours; GM-culture:
GM-CSF (Amgen)(1 Oul/ml) was aeleleelfor 24 hours; DM:
colchicine (Colcemiel-Gibco) was ilTIlTIediatly added.'x
Colchicine (0,4ul/ml) was added for the last two hours to
alI cultures anel then the material was spun at 1200r/nlin
for 8 min anel the sobrenaelant elischarged. For the CM 5,
elrops (Pasteur pipette) were taken out froln the lTIaterial
left from each culture or DM and put in 0.51TIIhypotonic
solution (elistilleel water). The cells were counteel in Cehn
CC 510 eletronic counter and adjusted to a final
concentration of 2 to 20xl03 cellshTIlTI.3 50 uI of this
solution was put into cytospin CalTIeraSand spun at 400r/
lTIin for 4 mino Meanwhile, cells were being counted
(around 5 to S minutes) hypotonization was taking place.
The slides were fixeel in cold fonTIalin-acetone solution
for 1 lTIin at the moment of use and then washed in Tris
buffered solution (TBS) pH 7.6 with 2.5% hUlTIan AB
serum (4:1) for 40 mino Then 20 uI OflTIOUSetnonoclonal
antibody (diluteel 1: 10) was dropped over the cells and
incubated for 60 lnin. After TBS wash rabbit anti-tnouse
Ig antibody (Dako Z 259) diluted 1: 10 in TBS with hunlan
AB SerUlTI(4: 1) for 40 min was added. Another TBS wash
and the APAAP complex (Dako D 651) was put over the
celIs for 40 lTIindiluteel I :50 in TBS. After wash alkalin
phophatase substrate was added diluteel in TBS with
levamisole I mM for 20 mino After final wash, the slides
were dried and stained for Harris Helnatoxilin for 5 lnin.
Blast celIs positivity was observed at the lnicroscope as
welI as positive and negative lnetaphases. Metaphases that
had chromosomal abnormalities were identifieel. Positive
control was done with lnarrow slides frotn the satne patient.
The specimens left over frotn the cultures or DM were
handled for conventional cytogenetic analysis, that is:
hypotonization with KCI 0.075M (I Otnl) for 20 tnin,
fixation with methanol-acetic acid solution (I :3)( 1OtnI), 3
washes in fresh made fixative, anel in the next elay the
slides were made, aged and bandeei for trypsin G
banding.19. Cytogenetic abnonnalities were elescribeel
following the International Systetn for Chrolllosollle
Nomenclature recotntnendations.20
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RESULTS:
TabIe 1 shows the cIassification of leukemias,
cytochemical reactions and immunophenotype. Case 1 was
a M2 AML with characteristic morphoIogy showing Auer
rods and pseudo-Chediaki-Higashi anomaly. The
karyotype showed Ioss ofY chromosolne and transIocation
t(8;21), an anomaIy seen in around 120/0 ofM2leukemias.
Case 2 was an ALL in reIapse with a hyperdiploid
karyotype and G banding was not obtained due to fuzzy
chromosomes. Case 3 was a typicaI M3 with t( 15;I 7).
. Cases 4 and 5 were M4 and M2 Ieukemias respectively,
with a very poor banding making it impossible to find
Table 1
Cytochemical reactions, FAB classification and immunophenotype of the leukemias
CASE DIAGNOSTIC POX SBB PAS aES NaF ASD AcF CD33 CD13 CD14 CD10 CD19 CD7 CD41 Slg
1 AML M2 99°10 100°10 10°10 95°10 95°10 72°10 52°10 25°10 26°10 13°10 o o o o 2°1o
2 ALL L1r - NEG 10°10 - - - - O O O 70°10 78°10 <1 °10 <1 °10 O
3 AML M3 100°10 100°10 DIF NEG NEG - - 92°10 86°10 1°10 100010d 3°1o <1 °10 <1 °10 O
4 AML M4 40°10 44°10 NEG 58°10 inhib - - 94°10 77°10 64°10 1°10 8°1o 10°10 3°1o 11°10
5 AML M2r 60°10 70°10 DIF TEC TEC - - 87°10 76°10 O O O O O O
6 AML M1 NEG 96°10 NEG NEG NEG 10°10 NEG 70°10 37°10 O O O O O O
7 AML M2Eo 100°10 100°10 NEG - - - + + O O O O O O
8 AML M1 40°10 90°10 NEG 30°10 30°10 - NEG 45°10 44°10 5°1o O O O <1% O
9 AML M3v 98% 99°10 DIF DIF DIF - NEG O 40°10 O O O O O O
10 AML M4L+ 71 °10 79°10 10°10 69°10 inhib 5% - 61 °10 15°10 60°10 O 23°10 O O O
11 ALLL1B NEG NEG NEG - - - NEG O O O 63°10 25°10 15°10 O O
12 AML M3 100°10 100°10 DIF 85°10 85% - - 89°10 18°10 O O O O O O
13 AML M4 5°1o - - 51 °10 inhib 9°1o - 15°10 48°10 28°10 <1 °10 <5°1o 4% 1°10 O
14 AML M1 90°10 100°10 NEG NEG NEG NEG 79°10 41°10 <1 °10 O <1 °10 45°10 <2°10 O
15 AML M1 98°10 99% 2°1o NEG NEG 1°10 - 77°10 <5°1o <5°1o O O 40% O <5%
16 Mixed L NEG NEG 39% 55°10 inipar NEG - 24% 22°10 <5°1o 37°10 35°10 12°10 <2°10 11°10
17 AML M2 84°10 96°10 DIF NEG NEG 50% NEG 21 °10 22°10 3°1o O 8°1o 1°10 1% O
18 AML M4 5°1o 20°10 DIF 56°10 inhib - - 66°10 4% 16°10 O O O O O
19 AML M1 94°10 100°10 DIF DIF DIF 23°10 - O O O O O O O O
20 AML M4Eo 63°10 92°10 NEG 70% inhib 21 °10 - 26% 27°10 2°1o O O 11°10 O O
21 CML MBC - 79°10 NEG - - - - 67°10 31% 6% O O 11°10 O O
22 AML M2 55°10 40°10 NEG NEG NEG - - 41°10 24°10 21 °10 O O 10°10 O O
aES= Alfa naftil acetate esterase
SBB= Sudam Black B
- = reaction not done
CD=cluster designation
DIF= difuse positivity
AcF= acid fosfatase
inhib= reaction inhibited
M4L+= M4 with Iymphoid component
ASD= naftol ASD acetate esterase
TEC= technical problem
0= negative result
MBC= myeloid blast crisis
Eo= eosinophilia
inipar= partial inhibition
L+= Iymphoid component
r= relapsed leukemia
Slg= surphace imunoglobuline
PAS= Periodic Acid Schiff
M3v= M3 hypogranular variant
NaF= inhibition by NaF
POX= peroxidase
NEG= negati.ve reaction
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Among the 22 patients studied, 18 were AML, being
Ml, M2 and M4 equally frequento Few cases of ALL in
this series is explained by the preponderance of adult
patients admitted to our infirmary.
There was 63% of karyotype abnonnalities. In The
Fourth International Workshop in Leukelnias,24 50% of
AML presented karyotype abnormalities. In later stuelies,
approximately 70 to 80% of cases of AML and 50% of
ALL have clonal acquired chromosolnal aberration of
leukemic cellS. 1.24.25.26.27
MAC method identifies the Inalignant cell anel
determines its lineage simultaneously in the intact cells.
This has been well demonstraded by other authors7.~.I()
Using MAC method with an APAAP kit, we wanteel
to check its feasibility as a rotinary procedure. We coulel
define the lineage as myeloiel in karyotypically abnonnal
cells only in few cases among 22 consecutevely stuelieel.
It becarne evident that cases with normal karyotype are
not suitable for this procedure since there remains as to
doubt whether the cytogenetically normal cell belongs to
the malignant clone or if it represents the nonnal residual
clone. In cases 15 and 18, wich did not present karyotype
abnormalities, we observed that all metaphases in the slieles
with CD 13 and CD33 were positive to these Inyeloid
markers. So we could imagine that in these cases nonnal
karyotype was representing malignant clone. Although one
can not be certain that cytogenetically nOrInal cells isolated
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structural abnormalities. Case 6 was a Ml
leukemia with a normal karyotype. Case
7 was a M2 AML with 8% of marrow
eosinophils and showed ano entirely
normal karyotype. Case 8 was a Ml
subtype with loss of part of the long arm
of chromosolne 5. Case 9 was a variant
M3 but t(15; 17) was not seen. Case 10
was an infant with leukemia presenting
t( 4; 11) and classified as monocytic
subtype with lymphoid component
following HURWTZ& MIRRO 21
criteria. Case 11 was a B cell ALL subtype
LI with loss of a chromosome of group
C and translocation involving long arm
of chrolnosome 1. Case 12 was a M3 with
deletion of part of long arm of
chrOlnosome 6 and additionaly, in some
metaphases monosomy 5. Case 13 was a
Figure 1 - Example of case 21 showing a metaphase positive to CO 33. The arrow
M4 leukemia with monosomy 7 in a indicates the Philadelphia chromosome. Positive and negative interphases are also
patient with previous exposition to toxic seen.
agents. Case 14 was a Ml with material
added to the short arm ofchromosome 16. Cases 15 and _D_IS~~_U_S~S_I~~N_:~~~~~~~~~~~~~
18 were Ml and M4 respectively, with normal karyotypes.
Case 16 has been published and was an ALL diagnosed
and treated with epipodophyllotoxin some years early and
now presenting relapse or a secondary mixed leukemia
with t(9;22) and additionaly, in some lnetaphases,
lnonosolny 1322.Case 17 was M2 with hypodiploidia. Case
19, Ml with normal karyotype, though negative showed a
imlnunophenotype presented overt positive peroxidase
(94%). Case 20 was a typical M4 with eosinophilia and
central nervous system infiltration and inversion of
chromosome 16. Case 21 was a CML in myeloid blast
crisis with only the persistence of Philadelphia
chromosome. Case 22 was a M2 in a 53-year-old patient
with a complex karyotype with monosomies 2 and 7,
translocations involving 1q and the presence of a marker
chrolnosome. Some of these patients (cases:
1,3,4,6,12,14,15,17,18 and 19) have been studied
correlating survival tÍlne and karyotype abnormalities. 23
Table 2 shows the karyotype and the results of CM.
In 14 cases there was some positivity to one or more MoAb
applied on the Inetaphase. But only in 4 cases (13,17,21
and 22) (Fig. 1) could we precisely define to which lineage
belonged the cell with cytogenetic abnormality. Among
the resting 10 cases, in 4 the karyotype was normal (cases
7, 9,15 and 18) avoiding identifications and in 6, small
abnonnalities were impossible to be seen through CM
(cases 1,8,12,14,16 and 20). In cases 8 and 12, karyotype
abnormality was seen only in GM cultures.
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Table 2
Karyotype and combined method results
CASE ARYOTYPE CULTURE COMBINED METHOD
CD
13 14 33 41 7 10 19
1 45,X,-Y,t(8;21 )(q22;q22) MTX + +
S O + -
DM O O O O O
~ 55,XX MTX
DM
~ 46,XX,t(15;17)(q22;q21 ) S - O
DM O O
4 46,XY S O
DM
~ 46,XX S
DM
~ 46,XX MTX
GM
t7 46,XX MTX +- +
GM O O
DM O O O
a 46,XY,del(5)( q23) MTX +- +
GM +-
DM O
~ 46,XY MTX +-
GM +-
DM
10 46,XX,t(4;11 )(q21 ;q23) MTX - -
S
11 45,XY,t(1 ;?),-C S O O
12 46,XX,del(6)(q15)/ MTX O
46,XX,-5,del(6)(q15)
GM +-
13 45,XX,-7 MTX + +
GM +-
14 46,XX,16q+ S + + -
GM +- +-
15 46,XX GM o o
s +
16 46,XY,t(9;11 )(p21 ;q23)/ GM O
45,XY,t(9;11 )(p21 ;q23),-13
S + + O
17 38,XY /41 ,XV S +- +
GM + +
18 46,XY GM + +
19 46,XX GM O O O
DM O O o
~O 46,XX,inv(16)(p13q22) S +- O O
GM +
DM o o o
~1 46,XY,t(9;22)(q34;q11 ) S +- +- +-
~2 45,XX,t(1 ;?)(q12;?),-2,-7,+mar S +- o o
Legend: MTX= culture with ametopterine; S=short term culture; GM=culture with GM-CSF; DM=direct method; + positive
stain; - negative stain; +- = concomitant presence of positive and negative mitosis; o absence of mitosis.
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froln tumor samples reaIly reflectthe karyotype profile of
the tumor.
The simultaneous presence of positive and negative
metaphases in MAC method, in 10 cases (7,8,9,12,
13, 14, 17,20,21 and 22) could indicate the proliferation
of ceIls of other lineages.
It became clear that unevident aberrations ar diploid
karyotype are very difficult to be seen through MAC
method, and in these cases probes for fluorescent in situ
hybridization (FISH) would help to point out the katyotype
abnormality (MACFISH technique).
SOlne cases, particularly the lymphoid ones,
presented very few metaphases to analyse through
conventional Inethod as weIl as through MAC. Pe~haps
this was due to different reasons such as low mitotic index,
slnaIl amount of ceIls aspirated from the patient, smaIl
nlllnber of metaphases put into cytospin, among other
technical problems.
Another interesting point to discuss was the
observation that MoAb positivity in MAC method using
APAAP was, lower when compared to indirect
immunofluorescence (IF) dane at diagnostic probably due
to a different pattern of reaction. 2X IF was dane immediatly
after aspiration ar coIlection of the samples and generaIly
presented positivity, while APAAP took a longer time to
1341
be dane and could present disappearence of cytoplaslnic
ar surphace antigen recognized by CD 33 (My 9) for
instance.2X Besides that, the ceIls stained for APAAP hael
been cultivated ar submitted to DM, ar in other worels,
had gane through handling that coulel explain the altereel
bindings to MoAb. Yet these cells had gane through
hypotonia and sweIli ng anel thus had suffereel
modifications that could alter surphace antigens.
In 2 cases (8 and 12), karyotype abnonnalities were
found only in GM culture. It has already been shown that
GM-CSF may induce proliferation of abnormal clonogenic
cells in human myeloid diseases such as AML anel
myelodysplastic syndromes. 2ó Leukemic cells froln bane
marrow have an increased response to GM-CSF in a pattern
caIled "leukemic specific", where there are stimulation of
cytogeneticaIly abnormal ceIls, prolif~rative advantage to
malignant ceIls in a mixed population (nonnal-abnonnal)
and a possible influence in the karyotype. 27.2lJ.30 This cOlllel
mean that GM induced the proliferation of Inalignant clonal
ceIls, and this aspect should be better studieel in fllture
works.
This study showed that the cOlnbined Inethoel is
feasible in cases with numerical ar evident. structural
chromosomal abnormalities', and not as a routine
procedure. Associated with probes for FISH, it will bring
much more interesting details.
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